IGF-IIR Activators

Manganese (II) chloride can activate the serine/threonine kinase Akt via the insulin signaling pathway. Akt activation promotes the translocation of GLUT4 transporters to the cell surface, a process also modulated by IGF-II/IGF-IIR, suggesting a convergence of insulin and IGF-II signaling at Akt. Increased GLUT4 translocation can suggest an upregulation of IGF-IIR activity due to the shared pathway with insulin signaling.

Forskolin activates adenylate cyclase, increasing intracellular cAMP levels, which in turn activate protein kinase A (PKA). PKA phosphorylates and activates the transcription factor CREB, which can enhance IGF-II gene transcription. Elevated IGF-II levels can upregulate IGF-IIR activity by increasing its ligand engagement and subsequent receptor-mediated functions.

Retinoic acid upregulates the expression of IGF-II mRNA in specific cell types. The increase in IGF-II synthesis leads to higher ligand availability for IGF-IIR, which can increase the receptor's activity by promoting its physiological functions, such as the endocytosis of IGF-II.

5-Azacytidine, a DNA methyltransferase inhibitor, can induce the demethylation of the IGF2/H19 locus, leading to the upregulation of IGF-II expression. Higher levels of IGF-II can interact with IGF-IIR, thereby increasing the receptor's functional activity due to the elevated ligand presence.

Sodium orthovanadate is an inhibitor of protein tyrosine phosphatases. By inhibiting dephosphorylation, it can enhance tyrosine phosphorylation on the insulin receptor substrate (IRS), which is also associated with IGF-II signaling. The phosphorylated IRS can interact with and activate PI3K, leading to downstream signaling that may enhance the effects of IGF-IIR by promoting its ligand IGF-II's actions.

Dehydroepiandrosterone (DHEA), an endogenous steroid hormone, can increase the transcription of IGF-II, providing more ligand for IGF-IIR, thus indirectly enhancing the receptor's activity.

Chloroquine raises endosomal pH, which can affect the receptor-mediated endocytosis process. As IGF-IIR is involved in the internalization of IGF-II, altering the endocytic pathway can enhance the activity of IGF-IIR by prolonging its interaction with its ligand.

Genistein is a tyrosine kinase inhibitor, but at lower concentrations, it paradoxically can enhance tyrosine phosphorylation of certain proteins. This can indirectly enhance IGF-II signaling through IGF-IIR by increasing the phosphorylation state of molecules within the signaling pathways shared with IGF-IIR, possibly affecting its activity.

Piceatannol inhibits the Syk kinase, which is involved in the modulation of cellular adhesion and the endocytic pathway. By inhibiting Syk kinase, piceatannol may alter the endocytic capacity of cells, potentially enhancing the receptor-mediated endocytosis function of IGF-IIR.

Spermine can modulate intracellular signaling pathways such as the Akt pathway, which interacts with the insulin/IGF signaling axis. By modulating Akt activity, spermine can influence the pathway in which IGF-IIR is involved, potentially enhancing the receptor's activation state due to an increase in IGF-II signaling.